BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2767768)

  • 1. Hepatitis B core antibody-negative HBsAg carriers.
    Vranckx R; Muylle L; Meheus A
    Infection; 1989; 17(4):250-1. PubMed ID: 2767768
    [No Abstract]   [Full Text] [Related]  

  • 2. [Detection of the DNA of the hepatitis B virus by molecular hybridization in HBsAg carriers and anemia patients].
    Granovskiĭ NN; Vlasikhina EM; Dotsenko GN; Uspenskiĭ MV; Zhdanov VM
    Vopr Virusol; 1986; 31(4):449-52. PubMed ID: 3765569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B virus DNA in hepatitis B surface antigen-positive blood donors: relation to the hepatitis B e system and outcome in recipients.
    Krogsgaard K; Wantzin P; Aldershvile J; Kryger P; Andersson P; Nielsen JO
    J Infect Dis; 1986 Feb; 153(2):298-303. PubMed ID: 3944482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [HBeAg and anti-HBe levels in HBsAg positive blood donors].
    Hasçelik G; Günalp A
    Mikrobiyol Bul; 1989 Jan; 23(1):23-9. PubMed ID: 2626096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum HBsAg, HBeAg, anti-HBe, and hepatitis B viral DNA in asymptomatic carriers in Taiwan.
    Chen DS; Lai MY; Lee SC; Yang PM; Sheu JC; Sung JL
    J Med Virol; 1986 May; 19(1):87-94. PubMed ID: 3701304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistence of "wild-type" and "e-minus" hepatitis B virus infection in chronic healthy HBsAg/anti-HBe positive carriers.
    Raimondo G; Meucci G; Sardo MA; Rodinò G; Campo S; Vecchi M; Pernice M; Rumi MG; Tatarella M; de Franchis R
    J Hepatol; 1994 Jan; 20(1):148-51. PubMed ID: 8201216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [HBeAg and anti-HBe in asymptomatic carriers of HBsAg and in various forms of hepatitis and liver cirrhosis].
    Kalinowska B; Nazarewicz-de Mezer T; Krawczyński K
    Przegl Epidemiol; 1984; 38(3):249-56. PubMed ID: 6528039
    [No Abstract]   [Full Text] [Related]  

  • 8. Hepatitis B virus infection in an institution for the mentally retarded.
    van Ditzhuijsen TJ; de Witte-van der Schoot E; van Loon AM; Rijntjes PJ; Yap SH
    Am J Epidemiol; 1988 Sep; 128(3):629-38. PubMed ID: 2970793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Application of hepatitis B virus DNA cloning in the diagnosis of infections related to hepatitis B virus].
    Bréchot C
    Ann Biol Clin (Paris); 1985; 43(4):351-4. PubMed ID: 3004263
    [No Abstract]   [Full Text] [Related]  

  • 10. Potential infectivity of blood from HBsAg asymptomatic carriers due to the presence of HBV-DNA and comparison with other markers of HBV infection.
    Tedeschi MV; Padilla CF; de Camargo IF; Yoshida CF
    Rev Inst Med Trop Sao Paulo; 1989; 31(6):377-83. PubMed ID: 2640512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Infectivity of hepatitis B].
    Gerken G
    Dtsch Med Wochenschr; 1996 Apr; 121(14):459. PubMed ID: 8665822
    [No Abstract]   [Full Text] [Related]  

  • 12. Incidence of hepatitis B virus DNA and DNA-polymerase in sera of Italian asymptomatic carriers with the serological markers of HBV.
    Carloni G; Delfini C; Colloca S; Alfani E; Taliani G; De Bac C
    Arch Virol; 1986; 87(1-2):97-105. PubMed ID: 3942507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type B hepatitis: virology, serology and clinical course.
    Hoofnagle JH
    Semin Liver Dis; 1981 Feb; 1(1):7-14. PubMed ID: 7051294
    [No Abstract]   [Full Text] [Related]  

  • 14. Anti-delta antibody in various HBsAg positive Argentine populations.
    Fay O; Tanno H; Palazzi J; Gatti H
    Prog Clin Biol Res; 1987; 234():517-8. PubMed ID: 3628422
    [No Abstract]   [Full Text] [Related]  

  • 15. [Determining hepatitis B virus markers in blood donors and patients by the immunoenzyme method].
    Golosova TV; Pobedinskaia IN; Vlasikhina EM; Margolina AN
    Gematol Transfuziol; 1986 May; 31(5):40-2. PubMed ID: 3522351
    [No Abstract]   [Full Text] [Related]  

  • 16. [Assessment of infectivity of carriers of hepatitis B antigen using viral DNA detection].
    Gerlich WH; Heermann KH; Uy A; Zyzik E; Thomssen R
    Offentl Gesundheitswes; 1987; 49(8-9):380-4. PubMed ID: 2958735
    [No Abstract]   [Full Text] [Related]  

  • 17. Hepatitis B virus DNA and e antigen in serum from blood donors in the United Kingdom positive for hepatitis B surface antigen.
    Harrison TJ; Bal V; Wheeler EG; Meacock TJ; Harrison JF; Zuckerman AJ
    Br Med J (Clin Res Ed); 1985 Mar; 290(6469):663-4. PubMed ID: 3918707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Serologic markers of hepatitis B virus. Recent progress].
    Mora Pérez I; Porres Cubero JC; Carreño García V
    Rev Clin Esp; 1984 Apr; 173(1):9-14. PubMed ID: 6330799
    [No Abstract]   [Full Text] [Related]  

  • 19. [Vertical transmission of viral hepatitis B].
    Guimarães RX; Ferraz ML; Kulay MN; Tedesco JJ; Ohashi MA; De Castilho MP
    Rev Paul Med; 1988; 105(5):254-8. PubMed ID: 3406623
    [No Abstract]   [Full Text] [Related]  

  • 20. Persistence of hepatitis B e antigen for a long period after the clearance of hepatitis B surface antigen.
    Tamura I; Shimase K; Ichimura H; Kurimura O; Kaneto E; Tsuchie H; Kurimura T
    Acta Virol; 1985 Dec; 29(6):505-8. PubMed ID: 2869663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.